Literature DB >> 22167190

Identification and characterization of an alternatively spliced isoform of the human protein phosphatase 2Aα catalytic subunit.

Deivid L S Migueleti1, Juliana H C Smetana, Hugo F Nunes, Jörg Kobarg, Nilson I T Zanchin.   

Abstract

PP2A is the main serine/threonine-specific phosphatase in animal cells. The active phosphatase has been described as a holoenzyme consisting of a catalytic, a scaffolding, and a variable regulatory subunit, all encoded by multiple genes, allowing for the assembly of more than 70 different holoenzymes. The catalytic subunit can also interact with α4, TIPRL (TIP41, TOR signaling pathway regulator-like), the methyl-transferase LCMT-1, and the methyl-esterase PME-1. Here, we report that the gene encoding the catalytic subunit PP2Acα can generate two mRNA types, the standard mRNA and a shorter isoform, lacking exon 5, which we termed PP2Acα2. Higher levels of the PP2Acα2 mRNA, equivalent to the level of the longer PP2Acα mRNA, were detected in peripheral blood mononuclear cells that were left to rest for 24 h. After this time, the peripheral blood mononuclear cells are still viable and the PP2Acα2 mRNA decreases soon after they are transferred to culture medium, showing that generation of the shorter isoform depends on the incubation conditions. FLAG-tagged PP2Acα2 expressed in HEK293 is catalytically inactive. It displays a specific interaction profile with enhanced binding to the α4 regulatory subunit, but no binding to the scaffolding subunit and PME-1. Consistently, α4 out-competes PME-1 and LCMT-1 for binding to both PP2Acα isoforms in pulldown assays. Together with molecular modeling studies, this suggests that all three regulators share a common binding surface on the catalytic subunit. Our findings add important new insights into the complex mechanisms of PP2A regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167190      PMCID: PMC3281656          DOI: 10.1074/jbc.M111.283341

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  ClusPro: a fully automated algorithm for protein-protein docking.

Authors:  Stephen R Comeau; David W Gatchell; Sandor Vajda; Carlos J Camacho
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.

Authors:  Michele LeNoue-Newton; Guy R Watkins; Ping Zou; Katherine L Germane; Lisa R McCorvey; Brian E Wadzinski; Benjamin W Spiller
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

3.  The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis.

Authors:  Mei Kong; Casey J Fox; James Mu; Laura Solt; Anne Xu; Ryan M Cinalli; Morris J Birnbaum; Tullia Lindsten; Craig B Thompson
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

Review 4.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 5.  Protein phosphatase 2A regulatory subunits and cancer.

Authors:  Pieter J A Eichhorn; Menno P Creyghton; René Bernards
Journal:  Biochim Biophys Acta       Date:  2008-06-03

6.  FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region.

Authors:  Eliana M Assmann; Marcos R Alborghetti; Maria E R Camargo; Jörg Kobarg
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

Review 7.  PP2A fulfills its promises as tumor suppressor: which subunits are important?

Authors:  Christine Van Hoof; Jozef Goris
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

8.  Alpha4 is an essential regulator of PP2A phosphatase activity.

Authors:  Mei Kong; Dara Ditsworth; Tullia Lindsten; Craig B Thompson
Journal:  Mol Cell       Date:  2009-10-09       Impact factor: 17.970

9.  Low resolution structure of the human alpha4 protein (IgBP1) and studies on the stability of alpha4 and of its yeast ortholog Tap42.

Authors:  Juliana Helena Costa Smetana; Cristiano Luiz Pinto Oliveira; Willy Jablonka; Thelma Aguiar Pertinhez; Flavia Raquel Gonçalves Carneiro; Monica Montero-Lomeli; Iris Torriani; Nilson Ivo Tonin Zanchin
Journal:  Biochim Biophys Acta       Date:  2006-02-17

10.  The structural basis for tight control of PP2A methylation and function by LCMT-1.

Authors:  Vitali Stanevich; Li Jiang; Kenneth A Satyshur; Yongfeng Li; Philip D Jeffrey; Zhu Li; Patrick Menden; Martin F Semmelhack; Yongna Xing
Journal:  Mol Cell       Date:  2011-02-04       Impact factor: 17.970

View more
  5 in total

Review 1.  Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.

Authors:  Godfrey Grech; Shawn Baldacchino; Christian Saliba; Maria Pia Grixti; Robert Gauci; Vanessa Petroni; Anthony G Fenech; Christian Scerri
Journal:  Tumour Biol       Date:  2016-07-21

2.  De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.

Authors:  Sara Reynhout; Sandra Jansen; Dorien Haesen; Siska van Belle; Sonja A de Munnik; Ernie M H F Bongers; Jolanda H Schieving; Carlo Marcelis; Jeanne Amiel; Marlène Rio; Heather Mclaughlin; Roger Ladda; Susan Sell; Marjolein Kriek; Cacha M P C D Peeters-Scholte; Paulien A Terhal; Koen L van Gassen; Nienke Verbeek; Sonja Henry; Jessica Scott Schwoerer; Saleem Malik; Nicole Revencu; Carlos R Ferreira; Ellen Macnamara; Hilde M H Braakman; Elise Brimble; Maura R Z Ruzhnikov; Matias Wagner; Philip Harrer; Dagmar Wieczorek; Alma Kuechler; Barak Tziperman; Ortal Barel; Bert B A de Vries; Christopher T Gordon; Veerle Janssens; Lisenka E L M Vissers
Journal:  Am J Hum Genet       Date:  2018-12-27       Impact factor: 11.025

3.  Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.

Authors:  Leticia Domínguez-Berrocal; Xiguang Zhang; Jean Marc Zini; Jesús Fominaya; Angelita Rebollo; Jerónimo Bravo
Journal:  Biomark Res       Date:  2016-05-04

4.  Crystal structure of the human Tip41 orthologue, TIPRL, reveals a novel fold and a binding site for the PP2Ac C-terminus.

Authors:  Valéria Scorsato; Tatiani B Lima; Germanna L Righetto; Nilson I T Zanchin; José Brandão-Neto; James Sandy; Humberto D'Muniz Pereira; Állan J R Ferrari; Fabio C Gozzo; Juliana H C Smetana; Ricardo Aparicio
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

5.  Systematic study of cis-antisense miRNAs in animal species reveals miR-3661 to target PPP2CA in human cells.

Authors:  Jian Wang; Zongcheng Li; Bailong Liu; Guangnan Chen; Ningsheng Shao; Xiaomin Ying; Ya Wang
Journal:  RNA       Date:  2015-11-17       Impact factor: 4.942

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.